Woll P, Gaunt P, Danson S, Steele N, et al. Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial. Lung Cancer 2022;171:26-33.
PMID: 35872530